Bivalirudin vs. Enoxaparin in Intubated COVID-19 Patients: A Pilot Multicenter Randomized Controlled Trial.

MLA

Garofalo, Eugenio, et al. “Bivalirudin vs. Enoxaparin in Intubated COVID-19 Patients: A Pilot Multicenter Randomized Controlled Trial.” Journal of Clinical Medicine, vol. 11, no. 20, Oct. 2022. EBSCOhost, https://doi.org/10.3390/jcm11205992.

APA

Garofalo, E., Cammarota, G., Neri, G., Macheda, S., Biamonte, E., Pasqua, P., Guzzo, M. L., Longhini, F., & Bruni, A. (2022). Bivalirudin vs. Enoxaparin in Intubated COVID-19 Patients: A Pilot Multicenter Randomized Controlled Trial. Journal of Clinical Medicine, 11(20). https://doi.org/10.3390/jcm11205992

Chicago

Garofalo, Eugenio, Gianmaria Cammarota, Giuseppe Neri, Sebastiano Macheda, Eugenio Biamonte, Pino Pasqua, Maria Laura Guzzo, Federico Longhini, and Andrea Bruni. 2022. “Bivalirudin vs. Enoxaparin in Intubated COVID-19 Patients: A Pilot Multicenter Randomized Controlled Trial.” Journal of Clinical Medicine 11 (20). doi:10.3390/jcm11205992.